Welcome, Guest  |  Login    Register

Continuous Manufacturing Spinout Scores Funding

A spinout firm from Novartis and MIT has received $2 million in venture funds to bring its vision of rapid, cost-effective continuous manufacturing to the pharmaceuticals market.
Popular Discussions A spinout firm from Novartis and MIT has received $2 million in venture funds to bring its vision of rapid, cost-effective continuous manufacturing to the ph… http://wiki.gilcommunity.com/discussion/continuous-manufacturing-spinout-scores-funding/

GSK, Novartis, Eli Lilly Deals Shake Up Global Pharma Sector

In a complex set of deals, drug giants GSK of the UK and Novartis in Switzerland have agreed to a multi-billion dollar exchange of assets to help reshape their businesses. In a separate deal, Novartis has also agreed to sell its animal health division to …
Popular Discussions In a complex set of deals, drug giants GSK of the UK and Novartis in Switzerland have agreed to a multi-billion dollar exchange of assets to help reshape the… http://wiki.gilcommunity.com/discussion/gsk-novartis-eli-lilly-deals-shake-global-pharma-sector/

Africa Manufacturing: Now GSK Launches $216 Million African Expansion Plan

More good news for the African manufacturing sector as global pharmaceutical giant GlaxoSmithKline (GSK) announced a $216 million investment plan to expand its research and manufacturing footprint across the continent over the next five years.
Popular Discussions More good news for the African manufacturing sector as global pharmaceutical giant GlaxoSmithKline (GSK) announced a $216 million investment plan to expand i… http://wiki.gilcommunity.com/discussion/africa-manufacturing-now-gsk-launches-216-million-african-expansion-plan/

Does Off-Shoring R&D Increase Risk?

Do manufacturers expose themselves to increased financial, legal, and regulatory risk when they elect to conduct product research and development activities in lower-cost developing countries?
Popular Discussions Do manufacturers expose themselves to increased financial, legal, and regulatory risk when they elect to conduct product research and development activities … http://wiki.gilcommunity.com/discussion/does-shoring-rd-increase-risk/

Should the Government Rate Plants on Quality?

In his influential 1979 book, "Quality is Free," Philip Crosby asserted that prevention of quality problems "is not hard to do. It is hard to sell." This has been particularly true in the pharmaceutical industry where buyers such as hospitals and doctors …
In his influential 1979 book, "Quality is Free," Philip Crosby asserted that prevention of quality problems "is not hard to do. It is hard to sell." This has been particularly … http://wiki.gilcommunity.com/discussion/should-government-rate-plants-quality/

Future Pharma: A Greener Way to Make More Drugs?

A groundbreaking research project to develop more sustainable manufacturing practices for the world’s pharmaceuticals industry was officially launched in Europe today. Led by UK pharmaceuticals giant GlaxoSmithKline(GSK) and researchers at the University…
A groundbreaking research project to develop more sustainable manufacturing practices for the world’s pharmaceuticals industry was officially launched in Europe today. Le… http://wiki.gilcommunity.com/discussion/future-pharma-greener-way-make-more-drugs/

Is Manufacturing Prowess Transportable to Vastly Different Industries?

Is it possible for a company that has established a reputation for manufacturing excellence in one industry to successfully apply what's it's learned in a completely different vertical industry? South Korea's Samsung Group is about to find out. The maker …
Is it possible for a company that has established a reputation for manufacturing excellence in one industry to successfully apply what's it's learned in a completely different ver… http://wiki.gilcommunity.com/discussion/manufacturing-prowess-transportable-vastly-different-industr/

Pharma Boosts Singapore Manufacturing

Singapore’s efforts to transition to a more (high-value manufacturing base, - Where Next For Expanding Pharma Contract Manufacturing Sector?) with a particular focus on pharmaceutical production, looks like it’s paying off big time.
Singapore’s efforts to transition to a more (high-value manufacturing base,  - Where Next For Expanding Pharma Contract Manufacturing Sector?) with a particular focus o… http://wiki.gilcommunity.com/discussion/pharma-boosts-singapore-manufacturing/

Drug Supply Chain Disruptions: The Government Steps In

Pharmaceutical manufacturers with US customers will face increased production monitoring and reporting requirements as a result of a new executive order signed Monday by President Obama. The order, intended to counter what has turned into an epidemic of m…
Pharmaceutical manufacturers with US customers will face increased production monitoring and reporting requirements as a result of a new executive order signed Monday by President… http://wiki.gilcommunity.com/discussion/drug-supply-chain-disruptions-government-steps/

Fake Pharma: Can New Supply Chain Technologies Help?

The World Health Organization estimates that up to 25% of the medicines now being consumed in the world’s poorest countries are fake – “deliberately and fraudulently mislabeled with respect to identity and/or source."
Related Articles Article 1 Article 2 Article 3 Stay in Touch               Not a Council Member? Click HERE to find out more about the Manufacturing Leadership … http://wiki.gilcommunity.com/discussion/fake-pharma-can-new-supply-chain-technologies-help/

Where Next For Expanding Pharma Contract Manufacturing Sector?

As the world’s major pharmaceutical companies rush to introduce innovative new drug products for world markets, their dependence on contract manufacturers to provide scalable manufacturing capacity looks set to increase rapidly over the next few years.
Related Articles Article 1 Article 2 Article 3 Stay in Touch               Not a Council Member? Click HERE to find out more about the Manufacturing Leadership … http://wiki.gilcommunity.com/discussion/where-next-expanding-pharma-contract-manufacturing-sector/

To Russia With Drugs Big Pharma Eyes Big Roubles Over Next Few Years

One of the hottest global pharmaceutical markets right now is in Russia. With a population of 142 million people, the country accounts for a third of the entire Central and Eastern European pharma market. Last year alone, Russian pharma sales expanded by …
Related Articles Article 1 Article 2 Article 3 Stay in Touch               Not a Council Member? Click HERE to find out more about the Manufacturing Leadership … http://wiki.gilcommunity.com/discussion/russia-drugs-big-pharma-eyes-big-roubles-over-next-few-years/

Wanted: Experienced Workforce. Will Relocate.

Pharmaceutal manufacturers are reportedly beginning to shift some production to locations in developed economies where they can more easily access experienced manufacturing employees.
Related Articles Article 1 Article 2 Article 3 Stay in Touch               Not a Council Member? Click HERE to find out more about the Manufacturing Leadership … http://wiki.gilcommunity.com/discussion/wanted-experienced-workforce-will-relocate/

Do Pharma Firms Need Better Supply Chain Analytics?

The global pharma business is sitting on an estimated $50 billion worth of excess inventory, according to studies by management consultants Accenture. As cheaper generic drugs become more readily available, that burden could cause a significant impact on …
Related Articles Article 1 Article 2 Article 3 Stay in Touch               Not a Council Member? Click HERE to find out more about the Manufacturing Leadership … http://wiki.gilcommunity.com/discussion/do-pharma-firms-need-better-supply-chain-analytics/

Does Pharma Need to Rethink Manufacturing?

It’s not great news for the drug business. Most of today’s pharmaceutical manufacturing and supply chain strategies are "inefficient, under-utilized, and ill-equipped to cope with new medicines," according to PricewaterhouseCoopers in its latest Pharma 20…
It’s not great news for the drug business. Most of today’s pharmaceutical manufacturing and supply chain strategies are "inefficient, under-utilized, and ill-equipped … http://wiki.gilcommunity.com/blog/does-pharma-need-rethink-manufacturing/

Does Pharma Have to Rethink Manufacturing?

It’s not great news for the drug business. Most of today’s pharmaceutical manufacturing and supply chain strategies are "inefficient, under-utilized, and ill-equipped to cope with new medicines," according to PricewaterhouseCoopers in its latest Pharma 20…
It’s not great news for the drug business. Most of today’s pharmaceutical manufacturing and supply chain strategies are "inefficient, under-utilized, and ill-equipped … http://wiki.gilcommunity.com/blog/does-pharma-have-rethink-manufacturing/

Blog Search

Blog Search


Search Results

Should the Government Rate Plants on Quality?  in
Posted by Unknown user on Feb 06, 2013
Views: 11266